Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma
<p> <b>S.V. Ivanova<sup>1</sup>, S.A. Kuleva<sup>1</sup>, N.N. Sadovnikova<sup>2</sup>, M.I. Komissarov<sup>2</sup>, M.N. Chistyakova<sup>2</sup>, <br> A.V. Khokhlova<sup>1</sup>, N.A. Shchegoleva&l...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | Russian |
| Published: |
Prime-Media
2020-11-01
|
| Series: | РМЖ "Клиническая офтальмология" |
| Online Access: | http://clinopht.com/upload/iblock/ba9/ba9302371b8a1a154436a849bcb66cda.pdf |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1841526787513778176 |
|---|---|
| author | S.V. Ivanova S.A. Kuleva N.N. Sadovnikova M.I. Komissarov M.N. Chistyakova A.V. Khokhlova N.A. Shchegoleva |
| author_facet | S.V. Ivanova S.A. Kuleva N.N. Sadovnikova M.I. Komissarov M.N. Chistyakova A.V. Khokhlova N.A. Shchegoleva |
| author_sort | S.V. Ivanova |
| collection | DOAJ |
| description | <p>
<b>S.V. Ivanova<sup>1</sup>, S.A. Kuleva<sup>1</sup>, N.N. Sadovnikova<sup>2</sup>, M.I. Komissarov<sup>2</sup>, M.N. Chistyakova<sup>2</sup>, <br>
A.V. Khokhlova<sup>1</sup>, N.A. Shchegoleva<sup>3</sup></b>
</p>
<p>
<b><sup>1</sup>N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, <br>
Russian Federation</b>
</p>
<p>
<b><sup>2</sup>St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation</b>
</p>
<p>
<b><sup>3</sup>K.A. Rauchfuss St. Petersburg Children’s City Multidisciplinary Clinical Center of High Medical Technologies, St. Petersburg, Russian Federation</b>
</p>
<p>
<i>Retinoblastoma is one of the most common retinal tumors in young children. Current early diagnostic and treatment strategies focus on the possibility to implement eye-preserving therapies. The 5-year overall survival for children with retinoblastoma is now 100%. First-line eye removal is recommended in extensive intraocular seeding and poor visual prognosis. The volume of adjuvant therapy is based on the histological risk factors for disease progression. This paper discusses the algorithms to determine risk factors and further systemic treatment strategy in several large study groups. Eye and even vision preservation is now possible in at least 65–75% of retinoblastoma patients. The paper also describes in detail the methods of locally administering chemotherapy which are considered eye-preserving treatment options, i.e., selective intra-arterial chemotherapy and intravitreal chemotherapy. Various physical methods of eye-preserving treatment which underwent significant deve lopment over the past decade are highlighted. In conclusion, the authors emphasize that retinoblastoma survivors, their siblings and offspring should be carefully monitored.</i>
</p>
<p>
<i><b>Keywords</b>: children, retinoblastoma, enucleation, polychemotherapy, selective intra-arterial chemotherapy, intravitreal chemotherapy, laser photocoagulation, transpupillary thermotherapy, cryotherapy, brachytherapy, monitoring.</i>
</p>
<p>
<i><b>For citation: </b>Ivanova S.V., Kuleva S.A., Sadovnikova N.N. et al. Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma. Russian Journal of Clinical Ophthalmology. 2020;20(4):197–203. DOI: 10.32364/2311-7729-2020-20-4-197-203.</i>
</p> |
| format | Article |
| id | doaj-art-335615c78a0b469b9bfea9a0462701be |
| institution | Kabale University |
| issn | 2311-7729 2619-1571 |
| language | Russian |
| publishDate | 2020-11-01 |
| publisher | Prime-Media |
| record_format | Article |
| series | РМЖ "Клиническая офтальмология" |
| spelling | doaj-art-335615c78a0b469b9bfea9a0462701be2025-01-16T09:39:39ZrusPrime-MediaРМЖ "Клиническая офтальмология"2311-77292619-15712020-11-0120431210Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastomaS.V. Ivanova0S.A. Kuleva1N.N. Sadovnikova2M.I. Komissarov3M.N. Chistyakova4A.V. Khokhlova5N.A. Shchegoleva6Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399Russian Journal of Clinical Ophthalmology, Publisher of «Medicina-Inform» Address for correspondence: Russia, 105064, Moscow, P.O. Box 399<p> <b>S.V. Ivanova<sup>1</sup>, S.A. Kuleva<sup>1</sup>, N.N. Sadovnikova<sup>2</sup>, M.I. Komissarov<sup>2</sup>, M.N. Chistyakova<sup>2</sup>, <br> A.V. Khokhlova<sup>1</sup>, N.A. Shchegoleva<sup>3</sup></b> </p> <p> <b><sup>1</sup>N.N. Petrov National Medical Research Center of Oncology, St. Petersburg, <br> Russian Federation</b> </p> <p> <b><sup>2</sup>St. Petersburg State Pediatric Medical University, St. Petersburg, Russian Federation</b> </p> <p> <b><sup>3</sup>K.A. Rauchfuss St. Petersburg Children’s City Multidisciplinary Clinical Center of High Medical Technologies, St. Petersburg, Russian Federation</b> </p> <p> <i>Retinoblastoma is one of the most common retinal tumors in young children. Current early diagnostic and treatment strategies focus on the possibility to implement eye-preserving therapies. The 5-year overall survival for children with retinoblastoma is now 100%. First-line eye removal is recommended in extensive intraocular seeding and poor visual prognosis. The volume of adjuvant therapy is based on the histological risk factors for disease progression. This paper discusses the algorithms to determine risk factors and further systemic treatment strategy in several large study groups. Eye and even vision preservation is now possible in at least 65–75% of retinoblastoma patients. The paper also describes in detail the methods of locally administering chemotherapy which are considered eye-preserving treatment options, i.e., selective intra-arterial chemotherapy and intravitreal chemotherapy. Various physical methods of eye-preserving treatment which underwent significant deve lopment over the past decade are highlighted. In conclusion, the authors emphasize that retinoblastoma survivors, their siblings and offspring should be carefully monitored.</i> </p> <p> <i><b>Keywords</b>: children, retinoblastoma, enucleation, polychemotherapy, selective intra-arterial chemotherapy, intravitreal chemotherapy, laser photocoagulation, transpupillary thermotherapy, cryotherapy, brachytherapy, monitoring.</i> </p> <p> <i><b>For citation: </b>Ivanova S.V., Kuleva S.A., Sadovnikova N.N. et al. Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma. Russian Journal of Clinical Ophthalmology. 2020;20(4):197–203. DOI: 10.32364/2311-7729-2020-20-4-197-203.</i> </p>http://clinopht.com/upload/iblock/ba9/ba9302371b8a1a154436a849bcb66cda.pdf |
| spellingShingle | S.V. Ivanova S.A. Kuleva N.N. Sadovnikova M.I. Komissarov M.N. Chistyakova A.V. Khokhlova N.A. Shchegoleva Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma РМЖ "Клиническая офтальмология" |
| title | Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma |
| title_full | Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma |
| title_fullStr | Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma |
| title_full_unstemmed | Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma |
| title_short | Retinoblastoma. Part 2. Treatment strategies for intraocular retinoblastoma |
| title_sort | retinoblastoma part 2 nbsp treatment strategies for intraocular retinoblastoma |
| url | http://clinopht.com/upload/iblock/ba9/ba9302371b8a1a154436a849bcb66cda.pdf |
| work_keys_str_mv | AT svivanova retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma AT sakuleva retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma AT nnsadovnikova retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma AT mikomissarov retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma AT mnchistyakova retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma AT avkhokhlova retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma AT nashchegoleva retinoblastomapart2nbsptreatmentstrategiesforintraocularretinoblastoma |